Press Releases
Published Articles
Latest Videos
Latest From The Blog
Newsletters
Happy New Year! AGT Newsletter – 2020 Edition
A STELLAR 2019 Has Positioned AGT For A SPECTACULAR 2020. I wanted to take a moment to sum up a great year of progress and success at AGT and to talk about potential milestones and significant inflection points ...
AGT Newsletter Volume 8
Featured Stories AGT’s HIV cure program is nearing a major milestone: Investigational New Drug (IND) submission. The IND is the key document that reports the safety data the FDA requires prior to a human trial...
AGT Newsletter Volume 7
Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
AGT Newsletter Volume 6
NEWSLETTER VOL. 6 AGT’s progress over the first half of 2018 has been tremendous: six patents granted, major advances in all of its key projects: HIV, PKU and immuno-oncology, substantial momentum on socia...
Join Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Latest AGT Tweets
The International Consortium For Cancer Gene & T Cell Therapy recently held its first meeting at @UniTorVergata to explore open science & responsibility in research & innovation. We were honored to be part of this historic step. About AGT's cancer research https://t.co/TDWbzfcI0u https://t.co/5VZWmXz8oy
The best hug of the year at AGT was from inspiring CEO @JeffreyGalvin, after AGT's clinical team surprised him with a copy of the IND they filed to the FDA to begin a human trial for an HIV #genetherapy. Galvin showed his appreciation to the team with this hug!
#NationalHugDay https://t.co/R5sMwxuR7e
"Faith is taking the first step even when you don't see the whole staircase"
Martin Luther King, Jr.
#MLKDay #MartinLutherKingJr https://t.co/50r7dahUtp
